Received Oct 16, 2025
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (AFLURIA) | SEQIRUS, INC. | 1 | AW1616A | IM / LA |
Patient received dose of Afluria from the 2024-2025 batch. Patient was notified upon discovery. Seqirus was contacted for guidance about need for additional care. Seqirus instructed that no additional action was needed. Patient did not report any side effects or adverse events.
NA
Unknown
Lorazepam, Progesterone, Vitamin D2, Meloxicam, Valacyclovir
NA
NA